Literature DB >> 21612145

The anti-inflammatory effects of ketamine: state of the art.

S Loix1, M De Kock, P Henin.   

Abstract

Inflammation is a major component in keeping the body in homeostasis. However, an overwhelmed inflammatory response may be associated to a loss of this homeostatic status, which may lead to tissue injury or organ dysfunction. A huge number of drugs interacts with the inflammatory response in a positive, negative or "dual" manner. Among these drugs, ketamine seems to have a significant positive effect on the regulation of inflammation. This NMDA-receptor antagonist acts at different levels of inflammation, interacting with inflammatory cells recrutment, cytokins production, and inflammatory mediators regulation. The resultant effect of these interactions confers to ketamine a anti-proinflammatory effect by limiting exacerbation of systemic inflammation without affecting local healing processes. This review makes a complete overview of the immunomodulatory properties of this complex anesthetic substance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21612145

Source DB:  PubMed          Journal:  Acta Anaesthesiol Belg        ISSN: 0001-5164


  41 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Ketamine Alters Hippocampal Cell Proliferation and Improves Learning in Mice after Traumatic Brain Injury.

Authors:  Austin J Peters; Laura E Villasana; Eric Schnell
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

Review 3.  The Expanding Role of Ketamine in the Emergency Department.

Authors:  Sophia Sheikh; Phyllis Hendry
Journal:  Drugs       Date:  2018-05       Impact factor: 9.546

4.  Ketamine for Refractory Status Epilepticus: A Systematic Review.

Authors:  Anna Rosati; Salvatore De Masi; Renzo Guerrini
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

Review 5.  Surgically induced neuropathic pain: understanding the perioperative process.

Authors:  David Borsook; Barry D Kussman; Edward George; Lino R Becerra; Dennis W Burke
Journal:  Ann Surg       Date:  2013-03       Impact factor: 12.969

6.  The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.

Authors:  L Canever; C S V Alves; G Mastella; L Damázio; J V Polla; S Citadin; L A De Luca; A S Barcellos; M L Garcez; J Quevedo; J Budni; A I Zugno
Journal:  Mol Neurobiol       Date:  2017-03-24       Impact factor: 5.590

Review 7.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 8.  Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic.

Authors:  John H Krystal; Chadi G Abdallah; Lynette A Averill; Benjamin Kelmendi; Ilan Harpaz-Rotem; Gerard Sanacora; Steven M Southwick; Ronald S Duman
Journal:  Curr Psychiatry Rep       Date:  2017-08-26       Impact factor: 5.285

9.  Antidepressant effects of C-Terminal domain of the heavy chain of tetanus toxin in a rat model of depression.

Authors:  Bruk Getachew; Liliana Mendieta; Antonei B Csoka; José Aguilera; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2019-05-22       Impact factor: 3.332

Review 10.  Mechanisms of ketamine action as an antidepressant.

Authors:  P Zanos; T D Gould
Journal:  Mol Psychiatry       Date:  2018-03-13       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.